Background {#Sec1}
==========

Image reconstruction in positron emission tomography (PET) is the process of forming an image data set that represents the spatial distribution of activity in the patient by using the detected coincidence events. The basic algorithm used since the mid-1970s to reconstruct the PET images is filtered back-projection (FBP) \[[@CR1]\]. Along with developments in computing power, new maximum likelihood (ML)-based reconstruction methods were developed that included accurate statistical Poisson-based noise models and physical modeling \[[@CR2]\]. These ML-based models were later combined with expectation--maximization (EM) algorithms \[[@CR3]\]. Compared to FBP, iterative reconstructions led, in most situations, to an improvement in (streaking) artifacts, noise, and resolution as it allowed accurate noise and physics/system models to be included \[[@CR4]--[@CR7]\]. Although the ML-EM reconstructions are accurate, the total reconstruction time is long due to the substantial computing power required per iteration and the many iterations required before convergence is reached. To accelerate the reconstruction process, new methods like ordered subset expectation maximization (OSEM) were developed \[[@CR8]\]. In OSEM, the measured data is divided into subsets (or blocks) and the EM algorithm is applied to each of these subsets \[[@CR9]\]. When all subsets are processed, the next iteration starts. The OSEM method is fast and currently one of the most applied in PET reconstructions. OSEM is, in contrast to ML-EM, not a true ML estimator; it does not converge to a maximum likelihood image \[[@CR10]\]. Moreover, since image noise increases with iterations, ML-EM and OSEM algorithms are usually stopped before the image becomes unacceptably noisy. Typically, some post-filtering is applied to enhance the images \[[@CR11]\].

Several studies reported quantitative differences comparing FBP to OSEM reconstructions \[[@CR12], [@CR13]\]. Most of these could be explained by other effects then the reconstruction process, like differences in attenuation correction, reconstruction filters, higher noise levels in FBP, or ROI selection \[[@CR14]\]. Higher uptake values are sometimes reported for OSEM, but this is almost completely reversible by equalizing the image resolution \[[@CR5], [@CR15]\].

In most cases, OSEM provides accurate quantitative results within 3%; however, larger biases (up to 50%) can be expected in regions with a 5- to 10-fold hotter background \[[@CR5]\]. This can partially be explained by differences in convergence rate in different regions. Cold regions within a hotter background converge at a different rate than hot regions within a colder background \[[@CR5]\]. Stopping early with iterating could therefore result in non-uniform recovery of activity \[[@CR16]\]. This means that, although the resulting images are visually appealing, e.g., hotspot detection in oncology, there could be inaccuracies in a quantitative assessment as the reconstruction algorithm did not reach full "convergence" in all image parts. Moreover, considering the high activity in the urinary bladder and kidneys, and the low background activity and higher tumor to background ratios with ^68^Ga-PSMA, the quantitative performance of OSEM may be reduced.

In addition to the previously mentioned reconstruction methods, there are also regularized iterative reconstruction methods. The penalized likelihood image reconstruction methods, like block sequential regularized expectation maximization (BSREM), add to the likelihood function a penalty function that controls image quality \[[@CR9], [@CR17]--[@CR20]\]. Due to this penalty function, which provides activity-dependent noise control and edge preservation while iterating, BSREM can run until full convergence is reached \[[@CR21]\]. This means that all image parts are fully converged, thereby increasing the accuracy in a quantitative assessment. Until recently, the penalized likelihood image reconstruction methods were not commonly used. Apart from the longer reconstruction times compared to OSEM, the resulting images of the edge-preserving penalized likelihood methods showed patchy background textures and other undesirable features \[[@CR22]\]. However, new developments show promising results.

In a study by Asma et al. \[[@CR23]\], lesions were inserted into multiple clinical whole-body PET/CT datasets in representative locations. These 'hybrid' datasets combine clinically realistic image backgrounds with known lesion activity. They found superior quantitation over early stopped and post-filtered OSEM, while maintaining clinically acceptable image quality. Ahn et al. \[[@CR21]\] extended this study with more clinical datasets from multiple clinical sites and included phantom measurements. Their results also demonstrated improvements in lesion quantitation accuracy compared to OSEM, especially in cold background regions such as lungs. Teoh et al. \[[@CR24]\] performed a phantom and clinical study. They found that the BSREM reconstructions were preferred over OSEM. A clinical evaluation study by Sah et al. \[[@CR25]\] indicated that time-of-flight (TOF) BSREM reconstructions showed the best results in all categories, independent of body compartments, compared to TOF OSEM. Due to recent improvements and these promising results, the BSREM algorithms are also becoming commercially available (e.g., Q.Clear, GE Healthcare, Waukesha, WI, USA).

Although the abovementioned studies show promising results with 2-deoxy-2-\[^18^F\]-fluoro-D-glucose (^18^F-FDG) on PET, the situation could be different for the ^68^Gallium-labeled tracer targeting the prostate-specific membrane antigen (^68^Ga-PSMA) as it has a clearly different uptake pattern compared to the ^18^F-FDG tracer used in most studies. The low background activity, higher tumor to background ratios, higher positron energy, and larger positron range could, e.g., have an effect on the performance \[[@CR20], [@CR26]\]. Moreover, previous studies were performed on PET/computed tomography (CT) whereas in this study, a PET/magnetic resonance (MR) is applied. This could also lead to differences as the current clinical PET/MR scanners have no attenuation coefficients for the bone in the MR-based attenuation map, except for the skull.

As BSREM runs until full convergence, the number of iterations and subsets are no controlling parameters in BSREM. BSREM does, however, have a regularization parameter *β*. It controls the global strength of the regularization, the relative difference penalty function.

Therefore, in this study, we investigate the optimal regularization parameter *β* for clinical ^68^Ga-PSMA PET/MR reconstructions in the pelvic region applying TOF BSREM in comparison to TOF OSEM.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

From a total of 125 patients referred to ^68^Ga-PSMA PET/MRI between June 2016 and January 2017, we retrospectively included 25 patients (median age 71 years, range 42--79; median body mass index 25.4 kg/m^2^, range 19.6--36.0 kg/m^2^) with ^68^Ga-PSMA PET positive pelvic lesions that provided written informed consent for retrospective use of their data. Of these, 16 patients were scanned for biochemical recurrence after radical prostatectomy and 9 patients were scanned for staging of a newly diagnosed high-risk prostate cancer. The study has been approved by the cantonal ethics committee.

PET/MR imaging {#Sec4}
--------------

To reduce the kidney, ureters, and urinary bladder activity during the scan, furosemide was injected intravenously (0.13 mg/kg) 30 min prior to ^68^Ga-PSMA-11 injection and patients were asked to void prior to the scan \[[@CR27]\]. After a standardized uptake time of 60 min, a clinical routine whole-body TOF PET/MRI (SIGNA PET/MR, GE Healthcare, Waukesha, WI, USA) was performed. For a similar scanner, the average spatial resolution in full with at half maximum (FWHM) for ^18^F at 1 cm off center was reported to be 4.2 mm, and 5.1 mm at 10 cm off center \[[@CR28]\]. The spatial resolution (FWHM) for ^68^Ga was 5.46, 5.26, and 6.10 mm (*x*, *y*, and *z*, respectively) in air and 5.63, 4.77, and 6.47 mm (*x*, *y*, and *z*, respectively) in water \[[@CR29]\]. The per crystal TOF timing resolution was less than 400 ps \[[@CR28], [@CR30]\].

Patients were positioned in supine position with the arms down. Clinical whole-body scans consist of 6 bed positions (2 min per bed), from the vertex of the skull to the mid-thighs. A 15-min 1 bed position PET/MR examination of the pelvic area was performed prior to or after the whole-body scan. Only 2-min emission data of the 15-min emission data was applied in this study to have datasets that are comparable to the clinical scan \[[@CR31]\]. During PET scanning, a default MR acquisition for attenuation correction was performed. For the pelvic area, additional anatomical MR sequences were acquired including an axial *T*~1~-weighted fast spin echo and an axial and coronal *T*~2~-weighted fast recovery fast spin echo. Dynamic contrast-enhanced sequences and diffusion-weighted imaging were added when deemed necessary for clinical evaluation.

PET reconstructions {#Sec5}
-------------------

All PET reconstructions (3D-TOF-OSEM and 3D-TOF-BSREM) were performed on a workstation running a PET reconstruction toolbox (PETtoolbox R1.28 MP24, GE Healthcare, Waukesha, WI, USA) for MATLAB (MATLAB R2017a, The MathWorks Inc., Natick, MA, USA). All PET reconstructions included the standard corrections like decay, scatter, random, dead time, attenuation, normalization, and the detector response. The reconstruction diameter was 60 cm, and the image grid was 256 × 256 with 2.34 × 2.34 × 2.78 mm^3^ voxels. All OSEM reconstructions were post-filtered in image space using an in-plane Gaussian convolution kernel with a full-width-at-half-maximum of 5.0 mm, followed by a standard axial filter with a three-slice kernel using relative weights of 1:4:1. These settings are commonly used in centers with a similar PET/MR scanner and result in optimal clinical images \[[@CR27], [@CR31]\]. BSREM reconstructions do not use post-filtering.

The PETtoolbox uses PET sinogram data and MR-based attenuation maps for the PET reconstructions. These datasets were copied from the PET/MR scanner to the workstation. All PET sinograms were created on the PET/MR scanner using 2-min TOF emission data from the pelvic region. All MR-based attenuation maps were created on the PET/MR scanner using a continuous fat-water-based attenuation correction method \[[@CR32]\].

### BSREM reconstructions and the *β* value {#Sec6}

The penalized likelihood function of BSREM is mathematically expressed as:$$\documentclass[12pt]{minimal}
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The relative difference penalty, which has the advantage of providing activity-dependent noise control, was introduced in \[[@CR33], [@CR34]\] and is given by$$\documentclass[12pt]{minimal}
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Unless specified otherwise, TOF BSREM reconstructions were initialized by 2 iterations of non-TOF OSEM and 3 iterations of non-TOF BSREM followed by 8 iterations of TOF BSREM, all with 28 subsets.

### Reference 3D TOF OSEM reconstructions {#Sec7}

As true SUV values are not known in clinical data, we used the 3D TOF OSEM reconstructions with 2 iterations and 28 subsets as reference for all other reconstructions. The applied 3D TOF OSEM reconstruction settings are the same as the clinical settings and were chosen as these resulted in the optimal PET images for the specified indication \[[@CR31]\]. In addition, 3D TOF OSEM reconstructions with 3 iterations and 28 subsets were performed, as a reference for too high background noise.

### The effect of the number of iterations/subsets {#Sec8}

To demonstrate the effect of the number of iterations and subsets on the image noise, we performed 2 series of reconstructions in one patient with 5 lesions: The first series was performed with 3D TOF OSEM using 28 subsets and 1, 2, 3, 4, 6, 8, 10, 12, 14, 16, 20, and 25 iterations. The second series was performed with 3D TOF BSREM using *β* values of 350, 400, 450, 500, and 700. With the PETtoolbox, we can set the number of subsets and the maximum number of iterations. This allowed us to stop the iterating process after 1, 2, 3, 4, 6, 8, 10, 12, 14, 16, 20, and 25 iterations with 28 subsets for each previously listed *β* value.

### The effect of the regularization parameter {#Sec9}

After demonstrating the effect of the number of iterations and subsets, we studied the effect of reconstruction parameter *β*, controlling the global strength of the regularization. For this, 3D TOF BSREM reconstructions were performed for all patient datasets using a range of 15 *β* values 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 700, 800, 900, 1000, and 1200. The lesions were divided into 3 sets according to their size and uptake, as measured on the reference 3D TOF OSEM reconstructions: A set of lesions having a small size (≤ 1 cm^3^) and low uptake (SUVmax ≤ 5 g/ml), a set of lesions having a large size (\> 10 cm^3^) or a high uptake (SUVmax \> 10 g/ml), and a set with the remaining lesions having medium size (1 cm^3^ \< volume ≤ 10 cm^3^) and medium uptake (5 g/ml \< SUVmax ≤ 10 g/ml).

Image analysis {#Sec10}
--------------

All images were analyzed on dedicated workstations (Advantage Workstation 4.6, GE Healthcare) and PMOD (v3.8, PMOD-Technologies LLC, Zurich, Switzerland), which allowed images to be viewed side-by-side as well as in fused mode. Regions of interest (ROIs) around lesions were drawn manually by an experienced nuclear medicine/radiology physician using PET, MR, and fused images on the PMOD workstation. Lesion size was automatically calculated based on the ROIs. For the background measurements, ROIs were drawn in uniform uptake regions in adipose/muscle tissue lateral and posterior to the hip joint. Next, the average standardized uptake value (SUVmean) and the standard deviation (SUVstd) in the background ROIs were calculated. The SUVstd was considered a measure for the background noise, and the uniform region allowed the measurement of small differences in noise \[[@CR35]\]. In every lesion, the SUVmax was defined and calculated by averaging the SUV values of the 5 hottest voxels to reduce the statistical noise induced by a single hottest voxel \[[@CR36]\].

In this study, we also defined a contrast recovery (CR) ratio comparing the tumor to background ratio of a TOF BSREM reconstruction (numerator) to the tumor to background ratio of the reference TOF OSEM reconstruction (denominator):$$\documentclass[12pt]{minimal}
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Statistical analyses {#Sec11}
--------------------

Statistical analyses were performed using Prism 7 (GraphPad Software Inc., San Diego, California, USA). Differences between medians were ascertained and compared using the Wilcoxon matched-pairs signed-rank test as it could not be proven (D'Agostino-Pearson omnibus normality test) that our distributions were Gaussian (except for the high (\> 900) *β* value reconstructions that are blurred most). A difference was considered to be statistically significant when *p* \< 0.05.

Results {#Sec12}
=======

The median-injected tracer dose was 128 MBq (range 105--161 MBq) which means a whole-body effective dose of 3.0 mSv. The average time difference between tracer injection and pelvis scan time was 53 min (standard deviation 21 min). After the PET images were reconstructed, a visual inspection was performed to exclude, e.g., reconstruction failures. All images were found to be as expected for the applied settings.

The effect of the number of iterations/subsets {#Sec13}
----------------------------------------------

The effect of the number of iterations/subsets on the reconstructed PET images is demonstrated in Fig. [1](#Fig1){ref-type="fig"}. We see that the number of iterations has a limited effect on SUVmean for both TOF OSEM and TOF BSREM reconstructions (Fig. [1a](#Fig1){ref-type="fig"}). However, we also see that the image noise (background SUVstd) increases significantly with the number of iterations in TOF OSEM (Fig. [1b](#Fig1){ref-type="fig"}). Too high noise levels can hamper clinical evaluations; and therefore, these TOF OSEM reconstructions are stopped after 2 iterations (Fig. [1](#Fig1){ref-type="fig"}b, at the arrow). This can also be visually appreciated in Fig. [2a](#Fig2){ref-type="fig"}--[c](#Fig2){ref-type="fig"} where we see an increase of image noise in the TOF OSEM reconstructions with 2, 3, and 8 iterations, respectively.Fig. 1Example dataset showing the effect of increasing iterations. The first two panels show the background SUVmean (**a**) and the SUVstd (**b**), as a function of the number of iterations, for TOF OSEM with 28 subsets and for TOF BSREM with regularization parameter *β* = 350, 400, 450, 500, and 700. The remaining 4 panels show the lesion SUVmax as a function of the number of iterations for 5 lesions (L1--L5) for TOF OSEM with 28 subsets (**c**) and for TOF BSREM with regularization parameter *β* = 350 (**d**), 400 (**e**), and 700 (**f**). The arrows indicate the default reference TOF OSEM reconstruction with 28 subsets and 2 iterations. SUV standardized uptake value, SUVmean the average value of the voxels in the background ROI, SUVstd the standard deviation of the values of the voxels in the background ROI, SUVmax the average of the hottest 5 voxels in the lesion, TOF time-of-flight, OSEM ordered subset expectation maximization, BSREM block sequential regularized expectation maximizationFig. 2Example dataset showing coronal PET maximum intensity projections (MIP) of the pelvic frame. PSMA accumulation is seen in the left ureter; besides the high activity in the primary tumor (green arrow), a small lymph node can be detected (red arrow). The reconstructions are TOF OSEM with 28 subsets and 2 (**a**), 3 (**b**), and 8 (**c**) iterations; TOF BSREM with regularization parameter *β* = 150 (**d**), 200 (**e**), 250 (**f**), 300 (**g**), 350 (**h**), 400 (**i**), 450 (**j**), 500 (**k**), 550 (**l**), 600 (**m**), 700 (**n**), 800 (**o**), 900 (**p**), 1000 (**q**), and 1200 (**r**). All images have SUV scale 0--10 g/ml. SUV standardized uptake value, TOF time-of-flight, OSEM ordered subset expectation maximization, BSREM block sequential regularized expectation maximization

In contrast to the TOF OSEM reconstructions, the image noise in TOF BSREM is (after the first few iterations) relatively constant (almost independent of the number of iterations) and its level depends on the *β* value (Fig. [1b](#Fig1){ref-type="fig"}). The TOF BSREM reconstructions with a *β* value of 400 and higher appear to have an equal or even lower background noise than the TOF OSEM with 2 iterations (Fig. [1b](#Fig1){ref-type="fig"}, at the arrow).

The example patient dataset included 5 lesions (L1--5 in Fig. [1c](#Fig1){ref-type="fig"}--[f](#Fig1){ref-type="fig"}) with volumes of 5.9, 0.3, 1.2, 0.4, and 0.3 cm^3^, respectively. The lesions were ordered according to their SUVmax in the reference TOF OSEM reconstruction with 28 subsets and 2 iterations (Fig. [1](#Fig1){ref-type="fig"}c, at the arrows). With only 2 iterations, it is likely that not all image parts are fully converged. If we would increase the number of iterations from 2 to 25, the lesion SUVmax would be closer to the real SUVmax of a fully converged image. We can see (Fig. [1c](#Fig1){ref-type="fig"}) that the SUVmax of the lesions is different at 2 iterations and 25 iterations. While with OSEM, we have to limit the number of iterations to 2 (due to the increase in image noise), with BSREM, we could iterate until full convergence. With TOF BSREM, the *β* value not only controls the noise (Fig. [1b](#Fig1){ref-type="fig"}), it also affects SUVmax (Fig. [1d](#Fig1){ref-type="fig"}--[f](#Fig1){ref-type="fig"}). The higher the *β* value, the lower the SUVmax and the lower the image noise.

The effect of the regularization parameter {#Sec14}
------------------------------------------

A total of 40 lesions were identified in the pelvic area of 25 patients. The box and whisker plots in Fig. [3](#Fig3){ref-type="fig"} show similar background SUVmean values for both TOF OSEM reconstructions with 2 and 3 iterations, and all 15 TOF BSREM reconstructions with varying *β* values (see also Table [1](#Tab1){ref-type="table"}). The image noise (SUVstd), however, decreases with increasing *β* values. A *β* value of 300 has approximately the same (too high) noise values (0.26 ± 0.07 g/ml, mean ± standard deviation) as the TOF OSEM reconstruction with 3 iterations and 28 subsets (0.26 ± 0.07 g/ml). A *β* value of 400 has, on average, the same image noise (0.21 ± 0.05 g/ml) as the reference TOF OSEM reconstruction with 28 subsets and 2 iterations (0.22 ± 0.06 g/ml) (see also Table [1](#Tab1){ref-type="table"}). A *β* value higher than 400 results, on average, in lower image noise as the reference TOF OSEM reconstruction. The 'H' in Fig. [3](#Fig3){ref-type="fig"}b indicates TOF BSREM reconstructions with significantly higher background noise compared to the reference TOF OSEM with 28 subsets and 2 iterations. These reconstructions are not recommended for clinical evaluations. This can also be visually appreciated in Fig. [2d](#Fig2){ref-type="fig"}--[r](#Fig2){ref-type="fig"} where we see a decrease of image noise in the TOF BSREM reconstructions going from *β* = 150 to *β* = 1200.Fig. 3Box and whisker plots showing SUVmean and SUVstd distributions from background ROIs in 25 patients. The left panel shows SUVmean (**a**) and the right panel shows SUVstd (**b**). Each panel shows from left to right the results of the TOF OSEM reconstructions with 28 subsets and 2 and 3 iterations, followed by TOF BSREM reconstructions with regularization parameter *β* = 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 700, 800, 900, 1000, and 1200. *H* indicates significantly higher values, and *L* indicates significantly lower parameter values for TOF BSREM compared to reference TOF OSEM. TOF time-of-flight, SUV standardized uptake value, SUVmean the average value of the voxels in the background ROI, SUVstd the standard deviation of the values of the voxels in the background ROI, OSEM ordered subset expectation maximization, BSREM block sequential regularized expectation maximizationTable 1The percentage increase/decrease for different parameters comparing 8 TOF BSREM reconstructions with reference TOF OSEM reconstructionsTOF BSREM*β* = 300*β* = 350*β* = 400*β* = 450*β* = 500*β* = 550*β* = 600*β* = 700Background SUVmean0.0% (0.60)0.0% (0.63)0.0% (0.65)0.1% (0.69)0.1% (0.67)0.1% (0.69)0.1% (0.75)0.1% (0.87)Background SUVstd22.0% (\< 0.01)\
*H*8.3% (\< 0.01)\
*H*−1.0% (0.41)− 9.2% (\< 0.01)\
*L*− 15.2% (\< 0.01)\
*L*−18.4% (\< 0.01)\
*L*− 21.0% (\< 0.01)\
*L*−27.0% (\< 0.01)\
*L*Small size, low-uptake lesions (*N* = 8)SUVmax28.0% (0.02)\
*H*17.7% (0.15)8.0% (0.55)−1.6% (0.74)− 8.1% (0.25)−12.8% (0.11)− 18.1% (0.05)\
*L*− 24.6% (0.02)\
*L*CR32.4% (0.02)\
*H*20.2% (0.15)8.1% (0.55)− 2.8% (0.74)−10.0% (0.15)−15.4% (0.08)− 21.6% (0.05)\
*L*− 29.3% (0.02)\
*L*Medium size, medium uptake lesions (*N* = 15)SUVmax27.0% (\< 0.01)\
*H*18.6% (\< 0.01)\
*H*14.5% (0.01)\
*H*10.5% (0.08)− 0.4% (0.64)− 3.3% (0.42)− 5.8% (0.21)− 10.6% (\< 0.01)\
*L*CR28.2% (\< 0.01)\
*H*20.4% (\< 0.01)\
*H*15.6% (0.02)\
*H*8.8% (0.15)0.1% (0.89)− 2.9% (0.42)− 5.5% (0.06)−12.4% (\< 0.01)\
*L*Large size, high-uptake lesions (*N* = 17)SUVmax16.3% (\< 0.01)\
*H*11.5% (\< 0.01)\
*H*7.0% (\< 0.01)\
*H*4.1% (0.01)\
*H*1.8% (0.19)0.3% (0.43)− 1.7% (0.89)− 4.9% (0.03)\
*L*CR17.4% (\< 0.01)\
*H*12.5% (\< 0.01)\
*H*9.1% (\< 0.01)\
*H*6.2% (\< 0.01)\
*H*2.9% (0.08)0.2% (0.46)− 1.9% (0.71)− 5.2% (0.02)\
*L*The regularization parameter applied in TOF BSREM is indicated by the *β* value (top). *P* values are listed in parentheses. *H* indicates significantly higher values, and *L* indicates significantly lower parameter values for TOF BSREM compared to reference TOF OSEM with 28 subsets and 2 iterations *SUV* standardized uptake value, *SUVmax* the average of the hottest 5 voxels in the lesion, *CR* the percentage increase of the tumor to background ratio of the indicated reconstruction compared to the reference TOF OSEM reconstruction with 2 iterations and 28 subsets, *TOF* time-of-flight, *OSEM* ordered subset expectation maximization, *BSREM* block sequential regularized expectation maximization

The effect of *β* on lesion SUVmax and CR is shown in Fig. [4](#Fig4){ref-type="fig"} for the 3 lesion subgroups: small size, low uptake; medium size, medium uptake; and large size, high uptake. A low *β* value of up to 350 will result in higher SUVmax values compared to the reference TOF OSEM, but also in higher image noise (Fig. [3](#Fig3){ref-type="fig"} and Table [1](#Tab1){ref-type="table"}). These reconstructed images are not clinically useful as the noise renders the lesions indistinguishable from background noise. A *β* value between 400 and 550 will, on average, result in higher or approximately equal SUVmax compared to the reference, with nearly equal or lower background noise (Fig. [4](#Fig4){ref-type="fig"} and Table [1](#Tab1){ref-type="table"}). A *β* value higher than 600 will result in not only lower SUVmax values but also lower background noise. The "L" in Fig. [4](#Fig4){ref-type="fig"} indicates TOF BSREM reconstructions with significantly lower SUVmax compared to the reference TOF OSEM with 28 subsets and 2 iterations. These BSREM reconstructions are not recommended for clinical evaluations where accurate SUV values are required. Due to the lower background noise, tumor detection could be easier, but this has to be proven in future studies.Fig. 4Box and whiskers plots showing SUVmax and CR distributions obtained from lesions in 25 patients. The left side shows SUVmax (**a**, **c**, and **e**), and the right side CR (**b**, **d**, and **f**). The top row (**a**, **b**) shows the group with small size and low-uptake lesions (*N* = 8), the middle row (**c**, **d**) shows the group with medium size and medium uptake lesions (*N* = 15), and the bottom row (**e**, **f**) shows the group with large size or high-uptake lesions (*N* = 17). Each subplot shows from left to right the results of the TOF OSEM reconstructions with 28 subsets and 2 and 3 iterations, followed by TOF BSREM reconstructions with regularization parameter *β* = 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 700, 800, 900, 1000, 1200. *H* indicates significantly higher values and *L* indicates significantly lower parameter values for TOF BSREM compared to reference TOF OSEM. CR = the tumor to background ratio of the indicated TOF reconstruction compared to the reference TOF OSEM reconstruction with 2 iterations and 28 subsets (Eq. 3), a CR value higher than 1 indicates a better tumor to background ratio for BSREM compared to OSEM. TOF time-of-flight, SUV standardized uptake value, SUVmax the average of the hottest 5 voxels in the lesion, OSEM ordered subset expectation maximization, BSREM block sequential regularized expectation maximization

This can also be visually appreciated in Fig. [2](#Fig2){ref-type="fig"} showing a large lesions with high uptake in the prostate (green arrow) and a small lymph node lesion with medium uptake (red arrow). Going from *β* = 400 to *β* = 1200 (Fig. [2i](#Fig2){ref-type="fig"}--[r](#Fig2){ref-type="fig"}), we see that the SUV of the small lymph node lesion decreases. On the higher *β* value images, the lymph node lesion has a similar SUV as the urinary bladder, making it disappear on the coronal maximum intensity projection (MIP) images. Figure [5](#Fig5){ref-type="fig"} shows the same lymph node lesion on axial images. We see that the lesion is located at a small distance from the urinary bladder. Due to this distance and due to the decrease in background noise with higher *β* values, it is still possible to detect the lymph node lesion on the *β* = 1200 image (Fig. [5f](#Fig5){ref-type="fig"}). Compared to the reference TOF OSEM (SUVmax = 7.3 g/ml), the SUVmax is higher on the TOF BSREM *β* = 400 (9.6 g/ml), but lower on the TOF BSREM *β* = 1200 (4.5 g/ml).Fig. 5Example dataset showing axial PET images of the pelvic frame. The reconstructions are TOF OSEM with 28 subsets and 2 iterations (**a**); TOF BSREM with regularization parameter *β* = 400 (**b**), 500 (**c**), 700 (**d**), 900 (**e**), and 1200 (**f**). All images have SUV scale 0--5 g/ml. Red arrow indicates the same lymph node lesion as in Fig. [2](#Fig2){ref-type="fig"}. It can be appreciated that the background noise decreases with increasing *β* values. It can also be appreciated that the SUV of the lymph node lesion decreases with increasing *β* values; however, the lesion is still clearly detectable even with *β* = 1200 (**f**). SUV standardized uptake value, TOF time-of-flight, OSEM ordered subset expectation maximization, BSREM block sequential regularized expectation maximization

Figure [6](#Fig6){ref-type="fig"} shows for each lesion its size, SUVmax, and the percentage change in CR compared to the reference TOF OSEM with 28 subsets and 2 iterations, which is also shown in Fig. [6a](#Fig6){ref-type="fig"}. With increasing *β*, the SUVmax and CR decrease for most lesions. Although all lesions are affected, the percentage decrease is larger for small lesions with low uptake. The lesion with the highest SUVmax, for example, has an approximate SUVmax value of 48 g/ml in TOF OSEM with 28 subsets and 2 iterations, and 55, 53, 52, 51, and 49 g/ml in TOF BSREM *β* = 350, 400, 450, 500, and 700, respectively. The corresponding CR is 13, 11, 8, 6, and 3% higher than BSREM compared to OSEM. With TOF BSREM *β* = 400, most lesions have higher SUVmax, although some low-uptake lesions have lower SUVmax compared to TOF OSEM and although most lesions have increased CR, several low-uptake lesions have decreased CR. With TOF BSREM *β* = 700 most lesions have lower SUVmax, and most low-uptake lesions have decreased CR, while high-uptake lesions have similar CR. This is in agreement with the results in Fig. [4](#Fig4){ref-type="fig"} and Table [1](#Tab1){ref-type="table"}, but now, the individual lesion with a specific SUVmax and size is shown.Fig. 6Scatterplots showing lesion size, SUVmax, and CR increase obtained in 25 patients. Each panel represents a different reconstruction: TOF OSEM with 28 subsets and 2 iterations (**a**), TOF BSREM with regularization parameter *β* = 350 (**b**), 400 (**c**), 450 (**d**), 500 (**e**), and 700 (**f**). The CR range was limited from − 50 to 50% for clarity. It can be appreciated that with increasing *β* value, the SUVmax and CR decreases in all lesions. SUV standardized uptake value, SUVmax the average of the hottest 5 voxels in the lesion, CR the percentage increase of the tumor to background ratio of the indicated reconstruction compared to the reference TOF OSEM reconstruction with 2 iterations and 28 subsets. TOF time-of-flight, OSEM ordered subset expectation maximization, BSREM block sequential regularized expectation maximization

Discussion {#Sec15}
==========

We investigated the effect of the regularization parameter *β* in TOF BSREM reconstructions of clinical ^68^Ga-PSMA PET acquisitions in the pelvic area. Our quantitative results indicate that the best *β* value for pelvic ^68^Ga-PSMA PET with TOF BSREM reconstructions is in the range between 400 and 550 for 2-min emission data and a median-injected dose of 128 MBq.

A *β* value near 400 will result in images having a similar background noise level and higher SUVmax values compared to reference TOF OSEM with 2 iterations and 28 subsets. These images could be used for clinical evaluations where accurate SUV values are required, like treatment evaluations and follow-up cases. A *β* value near 550 will result in images having a lower background noise level and similar SUVmax values. The low background noise could make tumor detection easier, but this has to be proven in future studies. Lower *β* values will result in higher SUVmax and more background noise, and higher *β* values will result in lower SUVmax and less background noise. The lower the *β* value, the lower the effect of the regularization function and the more the penalized likelihood function behaves like a normal likelihood function without noise control.

One clinical study performed with ^18^F-FDG on PET/CT found optimal *β* values in the range 350--400 for an injected mean dose of 297 MBq, 60 min uptake time, and 2 min per bed scans \[[@CR25]\]. A phantom/clinical study with ^18^F-FDG on PET/CT, with an injected dose of 288 MBq, 90 min uptake time, and 4 min per bed scans, found an optimal *β* value of 400 \[[@CR24]\]. These findings are slightly below the findings in our study. A higher injected dose and/or longer scan time could be a possible explanation for the lower *β* values in their study. Both ^18^F-FDG studies also noted that higher *β* values resulted in lower SUVmax.

Despite the fact that the penalized likelihood algorithms already exist for many years \[[@CR17], [@CR19]\], and the fact that the relative difference penalty by Nuyts et al. \[[@CR33], [@CR34]\], the BSREM by De Pierro et al. \[[@CR37]\], and the combination by Ahn et al. \[[@CR10]\], were already introduced some 15 years ago, these type of reconstruction methods were not used commonly in clinical routine. With todays improved computing power and after recent quantitative evaluations by, e.g., Asma et al. \[[@CR23], [@CR38]\] and Ahn et al. \[[@CR21]\] and clinical evaluations by, e.g., Ma et al. \[[@CR39]\], Passalaqua et al. \[[@CR40]\], Teoh et al. \[[@CR24]\], and Sah et al. \[[@CR25]\], which showed promising results, the TOF BSREM reconstruction method is now attracting more attention and is considered a possibly better alternative to OSEM.

Although OSEM reconstructions are fast, the early termination of the iteration process required to limit the noise, results in different convergence rates in different image regions. The TOF BSREM-penalized likelihood method applied in this study on the other hand achieves effectively full convergence, thereby improving the quantitative accuracy \[[@CR21]\]. The more accurate higher SUVmax values can play a crucial role in detecting small lesions, especially in regions with high background uptake like the liver or brain in ^18^F-FDG PET. Due to the slow convergence rates of OSEM in cold regions, like the lungs in ^18^F-FDG, or in regions near hot spots, like the kidneys or urinary bladder, BSREM's full convergence results in more accurate measurements in these areas \[[@CR21], [@CR24]\]. Besides the improved quantitative accuracy, the increase in SUVmax and the lower background noise with BSREM could possibly also be applied to further reduce the injected tracer dose, but this has to be proven in future studies.

Simulated phantom measurements are an optimal way to investigate certain aspects under specific circumstances, as parameters, like the ground truth, are known. Previous studies included "hybrid" phantom measurements in which lesions with a known activity were inserted in real patient datasets at interesting locations, near hotspots and in cold backgrounds \[[@CR21]\]. In this study, we used clinical patient data which has the advantage of a diverse patient population with lesions in commonly occurring locations. The disadvantage is that the ground truth is not available. We, however, used the same datasets for OSEM and BSREM, meaning that all parameters are the same, except for the reconstruction methods. This means that differences were only due to the differences in reconstruction methods.

The definition of SUVmax, as well as the ROI size and resolution can have a significant impact on measurements \[[@CR14], [@CR41]\]. In our study, we defined SUVmax as the average of the 5 hottest voxels, as the variability of this metric was found to be the lowest, compared to several other measures like the hottest voxel in a lesion \[[@CR36], [@CR42]\]. As all datasets in our study were obtained with the same scanner, and used for both the OSEM and BSREM reconstructions, it should not affect our results. Care has to be taken when comparing our results with other scanners or definitions.

In this study, for each dataset, the variable *β* was systematically increased in small steps and the resulting BRSEM reconstructions were compared with one OSEM reconstruction. The probability values (in Table [1](#Tab1){ref-type="table"}) were, however, not corrected for multiple comparisons. As adding more tests by "subsampling" the *β* value range will normally not result in accidental positive findings, we believe that it is better not to apply a correction.

This study has some limitations. The current study was, for example, performed on a relatively new TOF PET/MR system. Although we would expect comparable results on similar PET/MR or PET/CT systems, results may vary.

Significant halo artifacts have been reported to occur on many PET/CT and PET/MR systems with the use of 68Ga-PSMA-11. This is mainly due to high organ-to-background activity ratios between the bladder/kidneys and surrounding soft tissue, and due to incorrect scatter correction algorithms \[[@CR43], [@CR44]\]. In those cases, the administration of furosemide is recommended to substantially reduce bladder activity \[[@CR27]\]. The scanners in our institution have a second generation scatter correction algorithm installed, and, as a result, halo artifacts are rarely seen \[[@CR45], [@CR46]\]. Our patient cohort was reconstructed with the latest versions, and no halo artifacts were visible (Additional file [1](#MOESM1){ref-type="media"}: Figure S1 in Pizzuto et al. \[[@CR47]\] shows comparable scans).

Tissues surrounding high-activity areas, like the urinary bladder, could suffer from SUV overestimation as activity could spill into this region from the high-activity area \[[@CR48]\]. Proposed solutions range from bladder voiding by urinary catheterization to new segmentation and reconstruction methods \[[@CR49]\]. In our study, the administration of furosemide lowered the urinary bladder activity to a SUVmean of 7.7 g/ml (range 2.5--20.9 g/ml, interquartile range 8.9 g/ml, decay corrected). Three cases with the highest urinary bladder SUV showed similar surrounding SUV values as 3 cases with the lowest urinary bladder uptake. Therefore, the spill-in effect was considered minimal in our study.

Although we included a wide range of patients with different BMI values, the presented results are also expected to be related to the acquisition conditions (dose, uptake time, acquisition time, resolution, etc.) as specified in the materials section.

The pelvis region contains a large percentage of the bone, and MR-based attenuation correction (MR-AC) does generally not incorporate bone attenuation (except for the head). As a result, the average SUVmean of normal tissue in the pelvis region was found to have a bias of − 18.7% for non-TOF and − 10.8% for TOF, and lesions near the bone were reported to have a bias of − 5.2% for non-TOF and − 4.6% for TOF, compared to PET/CT using ^18^F-FDG and ^18^F-choline \[[@CR50]\]. Leynes et al. \[[@CR51]\] performed zero echo time (ZTE) scans in the pelvis region, which allows the imaging of the bones with MR. They segmented the data and combined it with the normal Dixon-based MR-AC map to include bone attenuation in their ^18^F-FGD TOF OSEM reconstructions. For bone lesions in the pelvis region, they found a SUVmax bias of − 10.8% comparing normal MR-AC to CT-AC, which was reduced to − 3.17% when applying their new hybrid ZTE method. For soft tissue lesions in the pelvis region, they found a SUVmax bias of − 7.67% which was further reduced to − 3.54%. In our study, the MR-based AC maps were the same for OSEM and BSREM and had no bone attenuation incorporated. When bone tissue would be included in the AC map, it would improve both the OSEM as well as the BSREM results. We did not investigate the effect of the bone in the attenuation map in the comparison between OSEM and BSREM, but we expect that BSREM will be superior to OSEM, considering the results obtained in other studies applying ^18^F-FDG PET/CT, which include the bone \[[@CR21]\]. It would be an interesting subject for future studies.

In this study, we did not perform a visual evaluation of the clinical image quality or the clinical significance. Therefore, it is unknown if TOF BSREM would lead to different diagnoses in ^68^Ga-PSMA PET of the pelvic area. However, the complex effects of the different *β* values on the behavior of absolute values, as well as on contrast and background, warranted a solid preliminary analysis of a wide range of *β* values. The current results give more insight and can be used to limit the amount of reconstructed PET images and thus evaluations to only those that are the most promising for further clinical investigations, which need to be performed in larger cohorts.

Conclusions {#Sec16}
===========

As ^18^F-FDG is the most commonly applied PET tracer, most studies evaluating the quantitative properties on PET images reconstructed with (TOF) BSREM were performed with this tracer. In our study, we showed that PET images reconstructed with TOF BSREM in combination with the ^68^Ga-PSMA tracer also results in lower background noise and higher SUVmax values in lesions, compared to TOF OSEM. Our study indicates that a *β* value between 400 and 550 might be an optimal compromise between high SUVmax and low background noise. Larger studies need to be performed to assess the clinical benefit of BSREM over OSEM.

Additional file
===============

 {#Sec17}

Additional file 1:**Figure S1.** Box and whisker plots showing tumor-to-background ratio distributions obtained from lesions in 25 patients. The top panel (a) shows the group with small size and low-uptake lesions (*N* = 8), the middle panel (b) shows the group with medium size and medium uptake lesions (*N* = 15), the lower panel (c) shows the group with large size or high-uptake lesions (*N* = 17). Each subplot shows from left to right the results of the TOF OSEM reconstructions with 28 subsets and 2 and 3 iterations, followed by TOF BSREM reconstructions with regularization parameter *β* = 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 700, 800, 900, 1000, and 1200. The tumor-to-background is defined as the SUVmax of the lesion devided by the SUVmean of the background. TOF = time-of-flight, SUV = standardized uptake value, SUVmax = the average of the hottest 5 voxels in the lesion, SUVmean = the average value of the voxels in the background ROI, OSEM = ordered subset expectation maximization, and BSREM = block sequential regularized expectation maximization. (DOCX 174 kb)

^18^F-FDG

:   2-Deoxy-2-\[^18^F\]-fluoro-D-glucose

3D

:   Three dimensional

^68^Ga-PSMA

:   ^68^Gallium-labeled tracer targeting the prostate-specific membrane antigen

AC

:   Attenuation correction

BKG

:   Background

BSREM

:   Block sequential regularized expectation maximization

CR

:   Contrast recovery

CT

:   Computed tomography

EM

:   Expectation--maximization

FBP

:   Filtered back-projection

ML

:   Maximum likelihood

MR

:   Magnetic resonance

OSEM

:   Ordered subset expectation maximization

PET

:   Positron emission tomography

REF

:   Reference

ROI

:   Region of interest

SUV

:   Standardized uptake value

TOF

:   Time-of-flight
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